Impact of metabolic syndrome on myocardial injury and clinical outcome after percutaneous coronary intervention;Einfluss des metabolischen Syndroms auf Myokardläsion und klinischen Verlauf nach perkutaner Koronarintervention

Herz

Volumn 40, Issue 1, 2015, Pages 129-135

  Li, J ^a,b   Song, S J ^b   Xu, J P ^b   Zhao, X Z ^b   Xu, Z W ^b   Sun, X J ^b   Wang, L F ^a   Yang, X C ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b HEBEI UNIVERSITY   (China)

Author keywords

Creatine kinase MB; Metabolic syndrome; Myocardial injury; Percutaneous coronary intervention; Troponin I

Indexed keywords

CHINA; COMORBIDITY; CORONARY ARTERY DISEASE; EPIDEMIOLOGY; FEMALE; HUMAN; INCIDENCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MYOCARDIAL STUNNING; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE COMPLICATIONS; RISK FACTOR; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME;

CAUSALITY; CHINA; COMORBIDITY; CORONARY ARTERY DISEASE; FEMALE; HUMANS; INCIDENCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MYOCARDIAL STUNNING; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; TREATMENT OUTCOME;

EID: 84939876070     PISSN: 03409937     EISSN: 16156692     Source Type: Journal    
DOI: 10.1007/s00059-014-4103-4     Document Type: Article

References (25)

1. Califf RM, Abdelmeguid AE, Kuntz RE et al (1998) Myonecrosis after revascularization procedures. J Am Coll Cardiol 31:241–251
2. Abdelmeguid AE, Topol EJ, Whitlow PL et al (1996) Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions. Circulation 94:1528–1536
3. Brener SJ, Ellis SG, Schneider J, Topol EJ (2002) Frequency and long-term impact of myonecrosis after coronary stenting. Eur Heart 23:869–876
4. Ioannidis JP, Karvouni E, Katritis DG (2003) Mortality risk conferred by small elevations of creatine kinase-MB isoenzyme after percutaneous intervention. J Am Coll Cardiol 42:1406–1411
5. Herrmann J (2005) Peri-procedural myocardial injury: 2005 update. Eur Heart J 26:2493–2519
6. Amano T, Matsubara T, Uetani T et al (2007) Impact of metabolic syndrome on tissue characteristics of angiographically mild to moderate coronary lesions integrated backscatter intravascular ultrasound study. J Am Coll Cardiol 49:1149–1156
7. Arai K, Ishii H, Amano T et al (2010) Volumetric analysis of coronary plaque characterization in patients with metabolic syndrome using 64-slice multi-detector computed tomography. Circ J 74:2146–2151
8. International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome. http://www.idf.org/webdata/docs/IDF_Meta_deffinal.pdf
9. Smith SC Jr, Dove JT, Jacobs AK et al (2001) Guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines) – executive summary. A report of the American College of Cardiology/American Heart Association Task Force on assessment of diagnostic and therapeutic cardiovascular procedures (Committee on percutaneous transluminal coronary angioplasty). J Am Coll Cardiol 37:2215–2239
10. Thygesen K, Alpert JS, White HD; The Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction (2007) Universal definition of myocardial infarction. Eur Heart 28:2525–2538
11. Marso SP, Mercado N, Maehara A et al (2012) Plaque composition and clinical outcomes in acute coronary syndrome patients with metabolic syndrome or diabetes. JACC Cardiovasc Imaging 5:S42–S52
12. Hong YJ, Mintz GS, Kim SW et al (2009) Impact of plaque composition on cardiac troponin elevation after percutaneous coronary intervention: an ultrasound analysis. JACC Cardiovasc Imaging 2:458–468
13. Uetani T, Amano T, Ando H et al (2008) The correlation between lipid volume in the target lesion, measured by integrated backscatter intravascular ultrasound, and post-procedural myocardial infarction in patients with elective stent implantation. Eur Heart 29:1714–1720
14. Uetani T, Amano T, Kunimura A et al (2010) The association between plaque characterization by CT angiography and post-procedural myocardial infarction in patients with elective stent implantation. JACC Cardiovasc Imaging 3:19–28
15. Yudkin JS, Juhan-Vague I, Hawe E et al (2004) Low-grade inflammation may play a role in the etiology of the metabolic syndrome in patients with coronary heart disease: the HIFMECH study. Metabolism 53:852–857
16. Ford ES (2003) The metabolic syndrome and C-reactive protein, fibrinogen, and leukocyte count: findings from the Third National Health and Nutrition Examination Survey. Atherosclerosis 168:351–358
17. Rodriguez CJ, Miyake Y, Grahame-Clarke C et al (2005) Relation of plasma glucose and endothelial function in a population-based multiethnic sample of subjects without diabetes mellitus. Am J Cardiol 96:1273–1277
18. Brook RD, Bard RL, Rubenfire M et al (2001) Usefulness of visceral obesity (waist/hip ratio) in predicting vascular endothelial function in healthy overweight adults. Am J Cardiol 88:1264–1269
19. Takaya J, Iwamoto Y, Higashino H et al (1997) Altered intracellular calcium and phorbol 12,13-dibutyrate binding to intact platelets in young obese subjects. J Lab Clin Med 129:245–250
20. Davì G, Guagnano MT, Ciabattoni G et al (2002) Platelet activation in obese women: role of inflammation and oxidant stress. JAMA 288:2008–2014
21. Arteaga RB, Chirinos JA, Soriano AO et al (2006) Endothelial microparticles and platelet and leukocyte activation in patients with the metabolic syndrome. Am J Cardiol 98:70–74
22. Anfossi G, Trovati M (2006) Pathophysiology of platelet resistance to anti-aggregating agents in insulin resistance and type 2 diabetes: implications for anti-aggregating therapy. Cardiovasc Hematol Agents Med Chem 4:111–128
23. Xu D, Guo Y, Wang H et al (2012) The angiographic and clinical outcomes after coronary stenting in patients with metabolic syndrome. Atherosclerosis 221:416–421
24. Nishino A, Kasai T, Miyauchi K et al (2011) Long-term effect of metabolic syndrome with and without diabetes mellitus on coronary revascularization in Japanese patients undergoing percutaneous coronary intervention. Clin Cardiol 34:610–616
25. Patsa C, Toutouzas K, Tsiamis E et al (2013) Impact of metabolic syndrome on clinical outcomes after new generation drug-eluting stent implantation: the ‘obesity paradox’ phenomenon is still apparent. Nutr Metab Cardiovasc Dis 23:307–313